© 2016 Novintum Medical Technology   -   Privacy Policy   -   Terms of Use

  • Facebook - Grey Circle
  • Twitter - Grey Circle
  • Google+ - Grey Circle

PHYSEON LATEST NEWS & UPDATES

February 12, 2019

Schaffhausen, Switzerland – February 12, 2019 – Physeon GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that its Veinplicity® Device was featured on a segment produced by ABC affiliate KSTP Chann...

February 7, 2019

Results Confirmed that Veinplicity Dilatory Effect is 38% Greater than Commonly Used Heat Packs

SCHAFFHAUSEN, Switzerland, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Physeon GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access,...

February 7, 2019

SCHAFFHAUSEN, Switzerland, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that Mayo Clinic and Gregory Schears, M.D., have been selected as a trial site...

December 18, 2018

Experienced Executives Join Physeon Team on Heels of Commencement of US VIVA Trial.

SCHAFFHAUSEN, Switzerland, December 17, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today an...

November 6, 2018

Recent Clinical Study Indicated Device had a Dilatory Effect 38% Greater than other Common Approaches for Veins Targeted for IV Access. Other studies indicate a First IV Stick Success Much Greater Than the Standard of Care.

SCHAFFHAUSEN, Switzerland, November 6, 2018 (G...

November 2, 2018

Recent Clinical Study Indicated Device had a Dilatory Effect 38% Greater than other Common Approaches for Veins Targeted for IV Access. Other studies indicate a First IV Stick Success Much Greater Than the Standard of Care.

SCHAFFHAUSEN, Switzerland, Oct. 29, 2018 (GLOB...

April 10, 2018

Recent Clinical Trial Indicated Device had a Dilatory Effect 38% Greater than Standard of Care

Physeon GmbH, a leading developer of medical technology products for venous access, today announced that it has selected The Regulatory and Clinical Research Institute, Inc.,...

April 9, 2018

Results Confirmed that Veinplicity Dilatory Effect is 38% Greater than Commonly Used Heat Pack

Physeon GmbH, a leading developer of medical technology products for venous access, today announced positive results from its first clinical trial with Veinplicity®.

...

March 27, 2018

Company’s New CEO Patrick Kullmann to Present on Opportunity for Novel and Disruptive Veinplicity Device

Physeon® GmbH, a leading developer of medical technology products for venous access, today announced that the Company will be a guest presenter at the “MedTech Stra...

March 27, 2018

Physeon® GmbH, a leading developer of medical technology products for venous access, today announced that the Company will attend the RESI “Early Stage Investors and Strategic Partners” meeting being held in Toronto, Canada on April 10, 2018. This meeting will match co...

Please reload

FEATURED POSTS

Physeon’s Veinplicity Device Featured on ABC Affiliate KSTP Channel 5; “VIVA” Trials Enrolling at Mayo Clinic

February 12, 2019

1/10
Please reload

RECENT POSTS
Please reload

ARCHIVE
Please reload